Antiviral agent (New Drug Development Division)
- Expansion of indications of hzVSF through various virus-infected cell experiments
- Continued clinical efficacy checks and feedback of hzVSF for the treatment of influenza and acute viral diseases
- Nonclinical and clinical studies of hzVSF for the treatment of chronic viral diseases
- Nonclinical and clinical studies for the development of therapeutic agents for skin diseases
- Partner management and licensing-out for licensing
